
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14881587
[patent_doc_number] => 10420813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Competitive inhibitors of invariant chain expression and/or ectopic clip binding
[patent_app_type] => utility
[patent_app_number] => 15/232856
[patent_app_country] => US
[patent_app_date] => 2016-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 47
[patent_no_of_words] => 62298
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232856 | Competitive inhibitors of invariant chain expression and/or ectopic clip binding | Aug 9, 2016 | Issued |
Array
(
[id] => 12044552
[patent_doc_number] => 09822145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Methods of making carfilzomib and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 15/228689
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4823
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/228689 | Methods of making carfilzomib and intermediates thereof | Aug 3, 2016 | Issued |
Array
(
[id] => 11350221
[patent_doc_number] => 20160368961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'Glycosylated Polypeptide and Drug Composition Containing said Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 15/213872
[patent_app_country] => US
[patent_app_date] => 2016-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 54835
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/213872 | Glycosylated polypeptide and drug composition containing said polypeptide | Jul 18, 2016 | Issued |
Array
(
[id] => 13958591
[patent_doc_number] => 20190055639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => FUNCTIONALIZED SURFACE
[patent_app_type] => utility
[patent_app_number] => 15/741194
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741194 | Functionalized surface | Jul 10, 2016 | Issued |
Array
(
[id] => 12302718
[patent_doc_number] => 09937264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Glycosylated polypeptide and drug composition containing said polypeptide
[patent_app_type] => utility
[patent_app_number] => 15/205960
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 44108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205960
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/205960 | Glycosylated polypeptide and drug composition containing said polypeptide | Jul 7, 2016 | Issued |
Array
(
[id] => 12885046
[patent_doc_number] => 20180186857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => FACTOR VIII PROTEIN COMPOSITIONS AND METHODS OF TREATING OF HEMOPHILIA A
[patent_app_type] => utility
[patent_app_number] => 15/736718
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736718 | Factor VIII protein compositions and methods of treating of hemophilia A | Jul 6, 2016 | Issued |
Array
(
[id] => 11106274
[patent_doc_number] => 20160303244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'GLUCOSE-RESPONSIVE INSULIN CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/191584
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 88975
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/191584 | Glucose-responsive insulin conjugates | Jun 23, 2016 | Issued |
Array
(
[id] => 16476224
[patent_doc_number] => 10851152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Polymerized peptide and gel having collagen-like structure
[patent_app_type] => utility
[patent_app_number] => 15/579286
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 46
[patent_no_of_words] => 22234
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579286
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579286 | Polymerized peptide and gel having collagen-like structure | Jun 22, 2016 | Issued |
Array
(
[id] => 13339799
[patent_doc_number] => 20180221439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => ANTIMICROBIAL FUSION PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/579926
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579926 | Antimicrobial fusion peptides | Jun 2, 2016 | Issued |
Array
(
[id] => 11588482
[patent_doc_number] => 20170112893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 15/172397
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 26070
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172397
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/172397 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | Jun 2, 2016 | Abandoned |
Array
(
[id] => 11067660
[patent_doc_number] => 20160264624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/171592
[patent_app_country] => US
[patent_app_date] => 2016-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 28665
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15171592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/171592 | Tubulysin compounds, methods of making and use | Jun 1, 2016 | Issued |
Array
(
[id] => 12733159
[patent_doc_number] => 20180136220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => CORRELATED PEPTIDES FOR QUANTITATIVE MASS SPECTROMETRY
[patent_app_type] => utility
[patent_app_number] => 15/571243
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571243
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571243 | Correlated peptides for quantitative mass spectrometry | May 30, 2016 | Issued |
Array
(
[id] => 11291780
[patent_doc_number] => 20160341713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein'
[patent_app_type] => utility
[patent_app_number] => 15/162598
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162598
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162598 | SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein | May 22, 2016 | Issued |
Array
(
[id] => 11271860
[patent_doc_number] => 20160334408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein'
[patent_app_type] => utility
[patent_app_number] => 15/156289
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5628
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156289
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156289 | SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein | May 15, 2016 | Issued |
Array
(
[id] => 11271864
[patent_doc_number] => 20160334411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'SRM/MRM Assay for the Mesothelin (MSLN) protein'
[patent_app_type] => utility
[patent_app_number] => 15/156282
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5509
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156282
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156282 | SRM/MRM assay for the mesothelin (MSLN) protein | May 15, 2016 | Issued |
Array
(
[id] => 11040161
[patent_doc_number] => 20160237116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/144397
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31557
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144397
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144397 | SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS | May 1, 2016 | Abandoned |
Array
(
[id] => 16954921
[patent_doc_number] => 11058749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Bioactive collagen biomaterials and methods for making
[patent_app_type] => utility
[patent_app_number] => 15/140885
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11023
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15140885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/140885 | Bioactive collagen biomaterials and methods for making | Apr 27, 2016 | Issued |
Array
(
[id] => 11114904
[patent_doc_number] => 20160311878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'THREE-HELIX BUNDLE PROTEIN AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/137942
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13082
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137942 | Three-helix bundle protein and use thereof | Apr 24, 2016 | Issued |
Array
(
[id] => 11023753
[patent_doc_number] => 20160220707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/132773
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55029
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132773 | Selective delivery molecules and methods of use | Apr 18, 2016 | Issued |
Array
(
[id] => 11025460
[patent_doc_number] => 20160222415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NUCLEAR TARGETING SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 15/097340
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23933
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15097340
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/097340 | Nuclear targeting sequences | Apr 12, 2016 | Issued |